Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Significant Decline in Short Interest

Key Points

• Shionogi & Co., Ltd. Unsponsored ADR experienced a 91.5% decrease in short interest in September, down to 25,900 shares from 304,400 shares at the end of August.
• The company's stock price fell 0.3% to $8.73 with a trading volume of 30,234 shares, compared to an average of 100,564 shares.
• Shionogi reported earnings of $0.16 per share for its last quarter, exceeding estimates, but revenue was lower than expectations at $672.90 million against a forecast of $719.55 million.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totaling 25,900 shares, a decrease of 91.5% from the August 31st total of 304,400 shares. Based on an average daily trading volume, of 118,600 shares, the short-interest ratio is currently 0.2 days. Based on an average daily trading volume, of 118,600 shares, the short-interest ratio is currently 0.2 days.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 0.3%

Shionogi & Co., Ltd. Unsponsored ADR stock traded down $0.03 during trading hours on Tuesday, reaching $8.73. 30,234 shares of the company's stock traded hands, compared to its average volume of 100,564. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.13 and a current ratio of 6.63. Shionogi & Co., Ltd. Unsponsored ADR has a fifty-two week low of $6.53 and a fifty-two week high of $9.23. The firm's 50 day moving average is $8.79 and its 200-day moving average is $8.38.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The company reported $0.16 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. The firm had revenue of $672.90 million during the quarter, compared to analyst estimates of $719.55 million. As a group, research analysts forecast that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.